Anthranilic acid derivatives

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 323/36 (2006.01) A61K 31/195 (2006.01) A61K 31/41 (2006.01) C07C 229/58 (2006.01) C07C 259/06 (2006.01) C07C 317/36 (2006.01) C07D 233/61 (2006.01) C07D 285/10 (2006.01) C07D 521/00 (2006.01)

Patent

CA 2349180

The invention features a compound having the formula (I) below. The invention also relates to a pharmaceutical composition including (a) a compound of formula (I) and (b) a pharmaceutically-acceptable carrier. The invention further relates to a method for treating proliferative diseases such as cancer, restenosis, psoriasis, autoimmune disease, and atherosclerosis. Other aspects of the invention include methods for treating MEK-related (including ras-related) cancers, whether solid or hematopoietic.

L'invention concerne des diarylamines pharmaceutiquement actifs, ainsi que leurs procédés de fabrication et d'utilisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anthranilic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anthranilic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthranilic acid derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1751136

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.